display
According to economists, pharmaceutical companies should be encouraged to deliver corona vaccines faster with bonuses.
"In view of the immense costs incurred by society as a result of the pandemic and the lockdowns across Europe, this premium should be very high," demand the economic experts Clemens Fuest, President of the Ifo Institute in Munich, and Daniel Gros, Member of the Board of Management at Center for European Policy Studies (CEPS) in Brussels, in a published article.
Both criticized the, in their opinion, not very binding conditions in the contracts with pharmaceutical manufacturers such as Astrazeneca and Biontech, "which now lead to a sluggish vaccination process".
The additional cost of increasing vaccine supply to Europe could amount to billions of euros.
“The premiums pay off anyway, because they would still be much cheaper than a longer lockdown of important parts of the EU with their annual economic output of 14 trillion euros,” said Fuest.
"Then there are the long-term costs of closing schools and, last but not least, the loss of human life."
display
Every additional dose of vaccine delivered this year is estimated to have a value of around 1500 euros for society, according to the article.
This is a multiple of the price, which is currently a maximum of 15 euros.
The premium should be staggered.
“It could start at a multiple of the original price, but decrease over time.
That would reduce the risk of deadlines not being met and give companies a strong incentive to speed up production. "
All developments on Corona in the live ticker: